Brian Mckelligon News Today

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $2.08, for a total value of $15,600.00. Following the completion of the sale, the chief executive officer now owns 224,733 shares of […]

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $2.08, for a total value of $15,600.00. Following the transaction, the chief executive officer now directly owns 224,733 shares […]

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,160,000 shares, an increase of 11.5% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 276,300 shares, the days-to-cover […]

Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Capital One Financial lowered their Q2 2024 EPS estimates for shares of Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will earn ($0.28) per share for the quarter, down from their prior estimate […]

Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Stock analysts at Capital One Financial dropped their Q2 2024 earnings per share estimates for Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will post earnings of ($0.28) per share for the quarter, […]

Akoya Biosciences (NASDAQ:AKYA – Free Report) had its price objective cut by Canaccord Genuity Group from $10.00 to $6.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently weighed in on AKYA. BTIG Research dropped their price target […]

KR-HT5 is based on Akoya’s PhenoImager® HT PlatformMARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 -- Akoya Biosciences, Inc. , The Spatial Biology Company®, and Shanghai KR Pharmtech, a...

Kent Lake Capital LLC lowered its holdings in shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) by 84.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 116,835 shares of the company’s stock after selling 629,686 shares during the period. Kent Lake Capital LLC’s holdings in Akoya Biosciences were worth $570,000 at the […]

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 […]

Akoya Biosciences (NASDAQ:AKYA – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $12.00 to $10.00 in a report released on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Other equities research analysts have also issued reports about the company. Piper Sandler decreased their price […]